CAS 2393840-15-6

LEI-401

CAS : 2393840-15-6

LEI-401

Degré de pureté : ≥98%

Masse moléculaire : 421.54g/mol

Ref: 54-BUP21783

LEI-401

CAS : 2393840-15-6

LEI-401 is a NAPE-PLD inhibitor.LEI-401 reduces the level of n-acyl ethanolamines in the brain of free-ranging mice and modulates their emotional behaviour.

Formule : C₂₄H₃₁N₅O₂

Degré de pureté : 99.79% - 99.79%

Couleur et forme : Solid

Masse moléculaire : 421.54

Ref: TM-T38001

LEI401

Produit contrôlé

CAS : 2393840-15-6

LEI401 is a drug that inhibits the Wnt/β-catenin signaling pathway. LEI401 has been shown to inhibit the growth of cancer cells in vitro and in animal models. It also shows efficacy against other types of cancers, such as leukemia and lymphoma, with possible applications for treatments of tumors. LEI401 is currently under investigation for its potential to treat Alzheimer's disease and Huntington's disease. In addition, LEI401 has been shown to have anthelmintic activity against nematodes (roundworms). The drug targets proteasomes in nematodes and causes premature protein degradation, leading to cell death.

Formule : C₂₄H₃₁N₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 421.24778

Ref: 3D-BL178105